Showing posts with label
Merck
.
Show all posts
Showing posts with label
Merck
.
Show all posts
Saturday, June 22, 2024
Agenus Inc. (formerly known as Agenus Therapeutics) is not claiming to be close to a cure for any form of cancer, but they are making significant strides in developing innovative cancer therapies.
›
"The rapid and complete resolution of aggressive MSS colorectal cancer tumors observed in this study is unprecedented in the field...
Thursday, June 13, 2024
Consolidation in the BioTech realm is a given going forward. Ginkgo Bioworks technology looks attractive to larger companies in the space!
›
Ginkgo Bioworks, a prominent player in the synthetic biotech market, could be a potential target for acquisition or merger, especially if co...
›
Home
View web version
